Clinical Trials on Advanced HCC

Total 6282 results

Shenyang Tenth People's Hospital
Beijing Tsinghua Changgeng Hospital

Not yet recruiting

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Advanced HCC
Tel-Aviv Sourasky Medical Center
Merck Sharp & Dohme LLC

Unknown

the Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC. (ZEPATIER)

HCV, HCC
Shanghai Kanda Biotechnology Co., Ltd.

Not yet recruiting

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Other Solid Tumors | Advanced HCC

China
Valérie LAURENT

Completed

CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy

Advanced HCC Treated by Systemic Immunotherapy

France
Hannover Medical School

Completed

Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma

Advanced HCC

Germany
Egyptian Liver Hospital

Completed

Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

HCC in Chronic HCV Patients With Advanced Liver Fibrosis
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Locally Advanced or Metastatic and Unresectable HCC

United States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Melanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCC

Korea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
University of California, Los Angeles
University of California, San Francisco; University of California, Irvine

Active, not recruiting

UC Health Care Planning Study

Advanced Cancer | Advance Care Planning | Advance Directives

United States
Qianfoshan Hospital

Not yet recruiting

Study of Serum Tumor Markers of HBV Associated HCC

HCC
University of Pisa
Azienda Ospedaliera Città della Salute e della Scienza di Torino; Fondazione... and other collaborators

Recruiting

Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC (SEASON-HCC)

HCC

Italy
Seoul National University Hospital
Philips Healthcare

Completed

"Double Low-Dose" DECT for HCC Imaging

HCC

Korea, Republic of
Huazhong University of Science and Technology

Unknown

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

HCC

China
Taipei Medical University WanFang Hospital

Terminated

Statin With Palliative Therapy for HCC

HCC

Taiwan
Leiden University Medical Center
Medtronic; ZonMw: The Netherlands Organisation for Health Research and Development and other collaborators

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

HCC | Early Stage HCC

Netherlands
Qianfoshan Hospital

Not yet recruiting

Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC

HCC
Xuhua Duan

Recruiting

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

HCC

China
Ain Shams University

Completed

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria

Hcc
Chen Xiaoping

Not yet recruiting

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

HCC
Henan Cancer Hospital

Not yet recruiting

Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients

HCC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Regina Elena Cancer Institute

Recruiting

Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres (DOSEY90)

HCC

Italy
The First Affiliated Hospital of Zhengzhou University

Unknown

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

HCC

China
feng xiaobin

Unknown

ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy

HCC

China
Betta Pharmaceuticals Co., Ltd.

Not yet recruiting

A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Lymphoma | HCC | NSCLC | Advanced Solid Tumor

China
Ain Shams University

Completed

TAURINE and HCC PATIENTS

Taurine in HCC

Egypt
Tang-Du Hospital
Xijing Hospital; Sun Yat-sen University; Shaanxi Provincial People's Hospital; Air... and other collaborators

Completed

A New Conception About Individualized Treatment Allocation for HCC (PTA4HCC)

HCC | Resection | Transarterial Chemoembolization
University of Bologna
University of Pisa; Azienda Ospedaliera Città della Salute e della Scienza... and other collaborators

Completed

Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy

HCC | Liver Transplant Disorder
Seoul National University Hospital
Bayer

Completed

Added Value of Gadoxetic Acid-enhanced Liver MRI

Diagnosis | Hcc

Korea, Republic of
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Sunshine Lake Pharma Co., Ltd.

Terminated

KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma

Advanced HCC

China
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC

Advanced Hepatocellular Carcinoma (HCC)

China, Singapore
Astellas Pharma Inc

Terminated

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

Advanced Hepatocellular Carcinoma (HCC)

Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
The University of Hong Kong
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy (START-FIT)

HCC

Hong Kong
Seoul National University Hospital
Taejoon Pharmaceutical Co., Ltd.; Reyon Pharmaceutical Co., Ltd.

Completed

A Study of HCC High Risk Group Using Two Surveillance Tools

HCC

Korea, Republic of
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC (LCRAI-1)

HCC
Zhejiang Haichang Biotech Co., Ltd.

Not yet recruiting

Phase 2 Study of WGI-0301 in Combination With Sorafenib for Advanced HCC

Advanced Hepatocellular Carcinoma (HCC)
Peking University Cancer Hospital & Institute

Recruiting

The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

China
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC

Advanced Hepatocellular Carcinoma (HCC)

Italy, Poland, Singapore, United States, China, Ukraine
The First Affiliated Hospital of Zhengzhou University
Anyang Tumor Hospital; Luoyang Central Hospital; Nanyang Central Hospital; Sanmenxia... and other collaborators

Recruiting

Novel Treatment of Advanced Hepatocellular Carcinoma (NTAHCC)

HCC

China
Istituto Clinico Humanitas

Completed

18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib

HCC

Italy
Assiut University

Unknown

Risk of HCC in Cirrhotic Patients Post DAAs Ttt

HCC
Beijing 302 Hospital

Unknown

OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI

HCC
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Active, not recruiting

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

HCC | Advanced Hepatocellular Carcinoma | Liver Cancer

United States
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Jiangsu HengRui Medicine Co., Ltd.

Terminated

A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Abramson Cancer Center of the University of Pennsylvania

Completed

Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)

ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

United States
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Shin Kong Wu Ho-Su Memorial Hospital

Completed

The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC

Advanced Hepatocellular Carcinoma (HCC)

Taiwan
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

China
Chugai Pharmaceutical

Completed

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Advanced or Metastatic HCC

United States

Clinical Trials on Advanced HCC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations